AYA Cancer Awareness Month: Patient Spotlights
Published on
CHOP’s Cancer Center provides special services for adolescent and young adult (AYA) patients. Meet some of those patients and learn about their journeys.
Cancer Center News and Updates
11 - 20 of 240
Researchers Show Lorlatinib is Safe, Effective for Patients with High-Risk Neuroblastoma
Published on
CHOP researchers have shown that adenovirus proteins use a process called phase separation to coordinate production of viral progeny, which could have broad implications.
Case Study: Precision Medicine for Infantile Fibrosarcoma
Published on
Levy traveled from Brazil and participated in a clinical trial for an oral drug that targets an NTRK gene fusion that drives cancer-cell growth.
CHOP Researchers Develop Tool that Reduces Errors in Stem Cell Transplant Reporting
Published on
CHOP researchers have developed a custom-built application to automate determination of engraftment, a key outcome after hematopoietic stem cell transplant.
Harnessing Data to Accelerate Discovery and Treatment of Brain Tumors
Published on
Through collaboration with research partners, patients, foundations, and community members, we are working to defeat childhood brain cancer and find better treatments for current patients. Read about recent milestones we’ve hit to accelerate pediatric brain tumor research.
Integrating Precision Medicine into Standard of Care for Children with Thyroid Cancer
Published on
Read this case study about integrating precision medicine into the standard of care for children with thyroid cancer.
ASH 2022: CHOP Experts Presented and Contributed to More than 200 Abstracts at National Hematology Conference
Published on
Nearly 50 faculty, staff and trainees from the Division of Hematology and Division of Oncology at Children’s Hospital of Philadelphia attended the 64th Annual American Hematology Society (ASH) Meeting in New Orleans, Louisiana.
Two CHOP Researchers Named 2022 STAT Wunderkinds
Published on
Two researchers from Children’s Hospital of Philadelphia (CHOP) were recently selected by the health and science news outlet STAT as 2022 Wunderkinds, an award that celebrates the next generation of scientific superstars who are making significant contributions to biomedical research.
New Study Shows AML Ages Immune Cells, Leading to Poor Treatment Response
Published on
A new study has found that acute myeloid leukemia (AML) ages and exhausts immune cells, impairing their ability to fight off cancer.
CHOP Researchers Show Liquid Biopsies Can Catch Disease Progression Early in High-Risk Neuroblastoma
Published on
CHOP researchers found that a series of “liquid biopsies” could less invasively and more accurately identify tumor changes in patients with high-risk neuroblastoma.